CareTrust REIT, Inc. (NYSE:CTRE) Plans $0.39 Quarterly Dividend

CareTrust REIT, Inc. (NYSE:CTRE) announced a quarterly dividend on Tuesday, September 15th. Stockholders of record on Wednesday, September 30th will be paid a dividend of 0.39 per share on Thursday, October 15th. This represents a c) dividend on an annualized basis and a dividend yield of 4.1%. The ex-dividend date of this dividend is Wednesday, September 30th.

CareTrust REIT has increased its dividend by an average of 0.1%annually over the last three years and has raised its dividend annually for the last 3 consecutive years. CareTrust REIT has a payout ratio of 102.0% meaning the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Analysts expect CareTrust REIT to earn $2.27 per share next year, which means the company should continue to be able to cover its $1.56 annual dividend with an expected future payout ratio of 68.7%.

CareTrust REIT Trading Up 0.9%

Shares of NYSE CTRE opened at $38.43 on Wednesday. CareTrust REIT has a 12-month low of $32.79 and a 12-month high of $43.62. The company has a market cap of $9.08 billion, a price-to-earnings ratio of 24.17, a price-to-earnings-growth ratio of 1.51 and a beta of 0.76. The company has a current ratio of 0.57, a quick ratio of 0.57 and a debt-to-equity ratio of 0.27. The stock’s 50 day simple moving average is $40.39 and its 200 day simple moving average is $39.69.

CareTrust REIT (NYSE:CTRE) last issued its earnings results on Thursday, August 6th. The company reported $0.51 earnings per share for the quarter, hitting the consensus estimate of $0.51. CareTrust REIT had a return on equity of 8.52% and a net margin of 62.19%.The firm had revenue of $161.35 million for the quarter. CareTrust REIT has set its FY 2026 guidance at 2.030-2.060 EPS. Equities research analysts expect that CareTrust REIT will post 2.04 EPS for the current year.

CareTrust REIT News Summary

Here are the key news stories impacting CareTrust REIT this week:

• Positive Sentiment: Acquisition expands the portfolio: CareTrust agreed to acquire a Southwest skilled-nursing portfolio for $400 million, effective September 1. The assets include 2,622 licensed beds and are triple-net leased to the existing operator, with long-term leases, inflation-based rent escalators and renewal options. The company also announced a reloaded acquisition pipeline totaling approximately $600 million. The deal may support future rental income and funds-from-operations growth. CareTrust REIT Acquires Skilled Nursing Portfolio for $400 Million; Announces $600 Million Reloaded Pipeline
• Positive Sentiment: Dividend maintained: The board declared a quarterly dividend of $0.39 per share, payable October 15 to shareholders of record September 30. The annualized payout is $1.56 per share, representing an indicated yield of approximately 4.1%, reinforcing CTRE’s income appeal. CareTrust REIT Announces Quarterly Dividend of $0.39 per Share
• Neutral Sentiment: Unusually heavy call-option activity: Traders purchased 3,705 call options, versus typical daily volume of 111, a roughly 3,238% increase. This suggests heightened bullish speculative interest, but options activity alone does not change CTRE’s fundamentals or guarantee continued share-price gains.

About CareTrust REIT

CareTrust REIT, Inc is a healthcare-focused real estate investment trust that owns and manages a portfolio of healthcare-related properties across the United States. The company primarily invests in properties that are leased to healthcare operators under long-term, typically triple-net lease agreements.

CareTrust’s portfolio includes skilled nursing facilities, assisted living facilities, independent living communities, memory care properties and other healthcare-related real estate. Its tenants are responsible for operating the facilities and generally cover property-level expenses such as taxes, insurance and maintenance under the terms of the leases.

CareTrust was established in 2014 through a separation from The Ensign Group, a healthcare services company.